TY - JOUR
T1 - Spontaneous tumor lysis syndrome in renal cell carcinoma
T2 - A case report
AU - Norberg, Scott Michael
AU - Oros, Michelle
AU - Birkenbach, Mark
AU - Bilusic, Marijo
N1 - Publisher Copyright:
© 2014 Elsevier Inc. All rights reserved.
PY - 2014
Y1 - 2014
N2 - Spontaneous tumor lysis syndrome (STLS) is a rare oncologic emergency caused by acute and massive death of tumor cells before the initiation of any anticancer therapy. It is commonly associated with aggressive hematological malignancies; however, it has been more frequently recognized in multiple solid tumors. Our literature search of STLS in solid tumors revealed common characteristics including extensive metastatic disease and increased levels of uric acid and lactate dehydrogenase. In this report, we describe, to our knowledge, the first case of STLS caused by a renal cell carcinoma and discuss the need for developing screening guidelines for this deadly syndrome.
AB - Spontaneous tumor lysis syndrome (STLS) is a rare oncologic emergency caused by acute and massive death of tumor cells before the initiation of any anticancer therapy. It is commonly associated with aggressive hematological malignancies; however, it has been more frequently recognized in multiple solid tumors. Our literature search of STLS in solid tumors revealed common characteristics including extensive metastatic disease and increased levels of uric acid and lactate dehydrogenase. In this report, we describe, to our knowledge, the first case of STLS caused by a renal cell carcinoma and discuss the need for developing screening guidelines for this deadly syndrome.
KW - Cairo-Bishop Criteria
KW - Lactate dehydrogenase
KW - Solid tumors
KW - Tumor necrosis
KW - Uric acid
UR - http://www.scopus.com/inward/record.url?scp=84922187608&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922187608&partnerID=8YFLogxK
U2 - 10.1016/j.clgc.2014.04.007
DO - 10.1016/j.clgc.2014.04.007
M3 - Article
C2 - 24999167
AN - SCOPUS:84922187608
SN - 1558-7673
VL - 12
SP - e225-e227
JO - Clinical Genitourinary Cancer
JF - Clinical Genitourinary Cancer
IS - 5
ER -
